Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 vs 5-FU in Metastatic Pancreatic Cancer
NCT00602745Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Feb 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of tegafur, sponsored by Sanofi. Started Feb 2008; status: terminated.
02
Drugs
tegafur
Beyond the preview
Go deeper on NCT00602745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00602745.